Cart
sales@molnova.com
USL311
CAS No. 1373268-67-7
USL311( —— )
Catalog No. M22471 CAS No. 1373268-67-7
USL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 106 | In Stock |
|
| 5MG | 178 | In Stock |
|
| 10MG | 259 | In Stock |
|
| 25MG | 434 | In Stock |
|
| 50MG | 627 | In Stock |
|
| 100MG | 893 | In Stock |
|
| 500MG | 1782 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUSL311
-
NoteResearch use only, not for human use.
-
Brief DescriptionUSL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
-
DescriptionUSL311 is a CXCR4 receptor antagonist which prevents the binding of stromal-cell derived factor-1 (SDF-1 or CXCL12) to CXCR4. USL311 inhibits CXCR4 activation and decreases proliferation and migration of CXCR4-expressing tumor cells, with anti-tumor activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetCXCR
-
RecptorCXCR4
-
Research AreaCancer
-
IndicationSolid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)
Chemical Information
-
CAS Number1373268-67-7
-
Formula Weight422.57
-
Molecular FormulaC24H34N6O
-
Purity>98% (HPLC)
-
SolubilityDMSO:24 mg/mL (59.79 mM; Need ultrasonic)
-
SMILESCC(C)N1CCC(CC1)N1CCCN(CC1)c1cccc(n1)C(=O)Nc1ccncc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Peter Richardson. Usl-311 for use in the treatment of cancer. WO2018162924A1
molnova catalog
related products
-
Ajmaline
Ajmaline is a class Ia anti-arrhythmic compound that is widely used for the diagnosis of Brugada syndrome and the acute treatment of atrial or ventricular tachycardia.
-
TC14012
TC14012, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 is a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 has anti-HIV activity and anti-cancer activity.
-
Syringaresinol-di-O-...
1. Syringaresinol-di-O-glucoside protects the animals from the stress-induced decreases in sex behaviours and in rectal temperature, the stress-induced failure of retrieval of memory, and the stress-induced enlargement of adrenal gland.
